Henry Schein (HSIC) Stock Price, News & Analysis

11 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Henry Schein in the last year. There are currently 1 sell rating, 5 hold ratings and 5 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" HSIC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in HSIC, but not buy additional shares or sell existing shares.
View HSIC analyst ratings or view top-rated stocks.

11 brokers have issued twelve-month target prices for Henry Schein's shares. Their HSIC share price targets range from $65.00 to $96.00. On average, they predict the company's stock price to reach $81.73 in the next twelve months. This suggests a possible upside of 12.3% from the stock's current price.
View analysts price targets for HSIC or view top-rated stocks among Wall Street analysts.

Henry Schein's stock was trading at $75.71 at the start of the year. Since then, HSIC stock has decreased by 3.9% and is now trading at $72.76.
View the best growth stocks for 2024 here.

Henry Schein saw a decline in short interest during the month of March. As of March 31st, there was short interest totaling 5,500,000 shares, a decline of 6.8% from the March 15th total of 5,900,000 shares. Based on an average daily volume of 1,140,000 shares, the days-to-cover ratio is presently 4.8 days. Currently, 4.3% of the company's shares are sold short.
View Henry Schein's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Monday, August 5th 2024.
View our HSIC earnings forecast.

Henry Schein, Inc. (NASDAQ:HSIC) issued its earnings results on Tuesday, May, 7th. The company reported $1.10 earnings per share for the quarter, beating the consensus estimate of $1.01 by $0.09. The business earned $3.17 billion during the quarter, compared to analyst estimates of $3.21 billion. Henry Schein had a net margin of 3.37% and a trailing twelve-month return on equity of 14.03%. Henry Schein's quarterly revenue was up 3.7% compared to the same quarter last year. During the same period last year, the company earned $1.21 earnings per share.
Read the conference call transcript.

ETFs with the largest weight of Henry Schein (NASDAQ:HSIC) stock in their portfolio include American Century Focused Large Cap Value ETF (FLV), SPDR S&P Health Care Services ETF (XHS), Invesco Bloomberg Analyst Rating Improvers ETF (RYJ), Invesco Bloomberg Analyst Rating Improvers ETF (UPGD), Invesco S&P 500 Equal Weight Health Care ETF (RYH), Invesco S&P 500 Equal Weight Health Care ETF (RSPH), Democratic Large Cap Core ETF (DEMZ) and First Trust Health Care AlphaDEX Fund (FXH).

Henry Schein shares split on Friday, September 15th 2017. The 2-1 split was announced on Wednesday, August 16th 2017. The newly issued shares were issued to shareholders after the market closes on Thursday, September 14th 2017. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Henry Schein declared that its Board of Directors has authorized a stock repurchase plan on Thursday, August 18th 2022, which allows the company to buyback $400,000,000.00 in outstanding shares, according to EventVestor. This buyback authorization allows the company to repurchase up to 4% of its stock through open market purchases. Stock buyback plans are often a sign that the company's leadership believes its shares are undervalued.

Henry Schein updated its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided EPS guidance of 5.000-5.160 for the period, compared to the consensus EPS estimate of 5.060. The company issued revenue guidance of $13.3 billion-$13.6 billion, compared to the consensus revenue estimate of $13.4 billion.

451 employees have rated Henry Schein Chief Executive Officer Stanley M. Bergman on Glassdoor.com. Stanley M. Bergman has an approval rating of 94% among the company's employees. This puts Stanley M. Bergman in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Henry Schein investors own include Alibaba Group (BABA), Pfizer (PFE), AbbVie (ABBV), Advanced Micro Devices (AMD), Intel (INTC), NVIDIA (NVDA), QUALCOMM (QCOM), CVS Health (CVS), Micron Technology (MU) and AT&T (T).

Henry Schein's stock is owned by a variety of retail and institutional investors. Top institutional investors include Perpetual Ltd (1.88%), Nuance Investments LLC (1.37%), Pzena Investment Management LLC (0.77%), Leith Wheeler Investment Counsel Ltd. (0.31%), Sei Investments Co. (0.30%) and Swiss National Bank (0.30%). Insiders that own company stock include Bradford C Connett, David B Brous Jr, Gerald A Benjamin, James P Breslawski, Kurt P Kuehn, Lorelei Mcglynn, Mark E Mlotek, Michael S Ettinger, Philip A Laskawy, Scott Philip Serota, Stanley M Bergman and Walter Siegel.
View institutional ownership trends.

Shares of HSIC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.